Advanced search
Publication Cover
Dermato-Endocrinology Volume 2, 2010 - Issue 1
Journal homepage
3,918
Views
170
CrossRef citations to date
0
Altmetric
Report

Comorbidities of hidradenitis suppurativa (acne inversa)

Sabine Fimmel Research Group for Biogerontology, Dermato-Pharmacology and Dermato-Endocrinology, Institute of Clinical Pharmacology and Toxicology, Campus Benjamin Franklin, Charité Universitaetsmedizin Berlin, Berlin, Germany
&
Christos C. Zouboulis Department of Dermatology, Venerology and Allergology, Dessau Medical Center, Dessau Germany
Pages 9-16 | Published online: 01 Apr 2010

Citations (170)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Hend M Alotaibi. (2023) Incidence, Risk Factors, and Prognosis of Hidradenitis Suppurativa Across the Globe: Insights from the Literature. Clinical, Cosmetic and Investigational Dermatology 16, pages 545-552.
Read now
Kevin Phan, William Hao Syuen Ng, Belinda Lai, Amit Garg & Saxon D. Smith. (2022) Hidradenitis suppurativa and association with stroke: systematic review and meta-analysis. Journal of Dermatological Treatment 33:4, pages 2309-2316.
Read now
Daniel J. Lee, Sapna Desai, Emily Laurent & Laura J. Kopplin. (2021) Characterization and Management of Inflammatory Eye Disease in Patients with Hidradenitis Suppurativa. Ocular Immunology and Inflammation 29:7-8, pages 1318-1323.
Read now
Claudio Marasca, Paolo Tranchini, Vincenzo Marino, Maria Carmela Annunziata, Maddalena Napolitano, Davide Fattore & Gabriella Fabbrocini. (2020) The pharmacology of antibiotic therapy in hidradenitis suppurativa. Expert Review of Clinical Pharmacology 13:5, pages 521-530.
Read now
Claudio Marasca, Maria Carmela Annunziata, Maddalena Napolitano & Gabriella Fabbrocini. (2018) Unconventional therapies for hidradenitis suppurativa. Expert Review of Clinical Pharmacology 11:9, pages 879-887.
Read now
Christina Fotiadou, Efstratios Vakirlis & Dimitrios Ioannides. (2016) Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa. Clinical, Cosmetic and Investigational Dermatology 9, pages 367-372.
Read now
Christos C. Zouboulis. (2016) Adalimumab for the treatment of hidradenitis suppurativa/acne inversa. Expert Review of Clinical Immunology 12:10, pages 1015-1026.
Read now
Dominique C. van Rappard, Jacqueline Limpens & Jan R. Mekkes. (2013) The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review. Journal of Dermatological Treatment 24:5, pages 392-404.
Read now
Sabela Paradela, Romina Rodríguez-Lojo, Rosa Fernández-Torres, Pilar Arévalo & Eduardo Fonseca. (2012) Long-term efficacy of infliximab in hidradenitis suppurativa. Journal of Dermatological Treatment 23:4, pages 278-283.
Read now
Jörg Reichrath. (2010) Dermato-Endocrinology . Dermato-Endocrinology 2:1, pages 1-2.
Read now

Articles from other publishers (160)

Grisell Starita-Fajardo, David Lucena-López, María Asunción Ballester-Martínez, Montserrat Fernández-Guarino & Andrés González-García. (2023) Treatment Strategies in Neutrophilic Dermatoses: A Comprehensive Review. International Journal of Molecular Sciences 24:21, pages 15622.
Crossref
Agnieszka Nowak-Liduk, Diana Kitala, Gabriela Ochała-Gierek, Wojciech Łabuś, Beata Bergler-Czop, Kornelia Pietrauszka, Paweł Niemiec, Karol Szyluk & Marcin Gierek. (2023) Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery—Pathogenesis, Comorbidities, and Current Treatments. Life 13:9, pages 1895.
Crossref
Evgeniya Hristakieva, Karen Manuelyan, Tanya Gancheva, Rositsa Lavcheva & Radostina Deliyska. (2023) Hidradenitis suppurativa from the typical patient to the new clinical phenotypes. Clinics in Dermatology 41:5, pages 584-591.
Crossref
Zrinka Bukvić Mokos, Adela Markota Čagalj & Branka Marinović. (2023) Epidemiology of hidradenitis suppurativa. Clinics in Dermatology 41:5, pages 564-575.
Crossref
Annelise Colvin & Lynn Petukhova. (2023) Inborn Errors of Immunity in Hidradenitis Suppurativa Pathogenesis and Disease Burden. Journal of Clinical Immunology 43:6, pages 1040-1051.
Crossref
Kathleen S Romanowski, Colette Galet, Marlon Torres & Lucy Wibbenmeyer. (2023) Evaluation of Outcomes Following Surgical Treatment of Hidradenitis Suppurativa. Journal of Burn Care & Research 44:4, pages 880-886.
Crossref
Anan Hammud, Emily Avitan-Hersh & Ziad Khamaysi. (2023) Clinical-Epidemiological Characteristics of Hidradenitis Suppurativa: A Retrospective Cohort Study from a Tertiary Care Centre in Northern Israel. Journal of Clinical Medicine 12:12, pages 3921.
Crossref
Ignacio Hernández Montilla, Alfonso Medela, Taig Mac Carthy, Andy Aguilar, Pedro Gómez Tejerina, Alejandro Vilas Sueiro, Ana María González Pérez, Laura Vergara de la Campa, Loreto Luna Bastante, Rubén García Castro & Fernando Alfageme Roldán. (2023) Automatic International Hidradenitis Suppurativa Severity Score System (AIHS4): A novel tool to assess the severity of hidradenitis suppurativa using artificial intelligence. Skin Research and Technology 29:6.
Crossref
Isabelle D Brown, Waleed Adawi, Ryan Saal, Kala Perkins-Holtsclaw & Alice Roberts. (2023) Associations between hidradenitis suppurativa and dermatological conditions in adults: a national cross-sectional study. Clinical and Experimental Dermatology 48:5, pages 524-527.
Crossref
Mathieu Daoud, Mariano Suppa, Farida Benhadou, Mathilde Daxhelet, Hassane Njimi, Jonathan White, Gregor Jemec & Véronique del Marmol. (2023) Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data. Frontiers in Medicine 10.
Crossref
Mika Yamanaka-Takaichi, Rishab Revankar, Terri Shih, Margaret Gall, Jennifer L. Hsiao, Vivian Y. Shi & Afsaneh Alavi. (2023) Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study. Archives of Dermatological Research 315:7, pages 2129-2136.
Crossref
Rishab Revankar, Mary Rojas, Samantha Walsh, Heli Patel, Nikita Revankar, Joseph Han & Anupama Parameswaran. (2023) Anemia in patients with hidradenitis suppurativa. Archives of Dermatological Research 315:6, pages 1639-1648.
Crossref
Michael Schultheis, Petra Staubach‐Renz, Stephan Grabbe, Katharina Hennig, Fareed Khoury, Georgios Nikolakis & Uwe Kirschner. (2023) Können Acne‐inversa‐Patienten ihre Läsionen mit Hilfe eines digitalen Läsionsidentifikationsschemas klassifizieren?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 21:1, pages 27-34.
Crossref
Michael Schultheis, Petra Staubach‐Renz, Stephan Grabbe, Katharina Hennig, Fareed Khoury, Georgios Nikolakis & Uwe Kirschner. (2023) Can hidradenitis suppurativa patients classify their lesions by means of a digital lesion identification scheme?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 21:1, pages 27-32.
Crossref
Jaime Cordero-Ramos, Vicente Merino-Bohórquez, Mercedes Delgado-Valverde, Rubén Barros-Tornay, Manuel Cameán-Fenández & Miguel Ángel Calleja-Hernández. (2022) Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. European Journal of Hospital Pharmacy 29:6, pages 313-318.
Crossref
U. Radhakrishna, U. Ratnamala, D.D. Jhala, N. Vadsaria, M. Patel, L.V. Uppala, S. Vishweswaraiah, A. Vedangi, N. Saiyed, G. Damiani & G.B.E. Jemec. (2022) Methylated miRNAs may serve as potential biomarkers and therapeutic targets for hidradenitis suppurativa . Journal of the European Academy of Dermatology and Venereology 36:11, pages 2199-2213.
Crossref
Leah A. Johnston, Raed Alhusayen, Marc Bourcier, Isabelle Delorme, Ralph George, Elizabeth O’Brien, Se Mang Wong & Susan M. Poelman. (2022) Practical Guidelines for Managing Patients With Hidradenitis Suppurativa: An Update. Journal of Cutaneous Medicine and Surgery 26:2_suppl, pages 2S-24S.
Crossref
Thrasyvoulos Tzellos & Christos C. Zouboulis. (2022) Which hidradenitis suppurativa comorbidities should I take into account?. Experimental Dermatology 31:S1, pages 29-32.
Crossref
Ellie Choi, Sartaj Ahmad Mir, Shanshan Ji, Xue Ting Ooi, Esther W.L. Chua, Yeo Yi Wei, Markus R. Wenk, Anne K. Bendt & Nisha Suyien Chandran. (2022) Understanding the systemic burden of disease in hidradenitis suppurativa from plasma lipidomic analysis. Journal of Dermatological Science 107:3, pages 133-141.
Crossref
Igors Iesalnieks. (2022) Sinus pilonidalis und Hidradenitis suppurativa: 2 anspruchsvolle HauterkrankungenPilonidal disease and hidradenitis suppurativa: challenging skin conditions. Die Gastroenterologie 17:4, pages 252-260.
Crossref
Malgorzata Orylska-Ratynska, Waldemar Placek & Agnieszka Owczarczyk-Saczonek. (2022) Tetracyclines—An Important Therapeutic Tool for Dermatologists. International Journal of Environmental Research and Public Health 19:12, pages 7246.
Crossref
Amie Patel, Anjali Patel, Dhanshree Solanki, Uvesh Mansuri, Aanandita Singh, Purnima Sharma & Shantanu Solanki. (2022) Hidradenitis Suppurativa in the United States: Insights From the National Inpatient Sample (2008-2017) on Contemporary Trends in Demographics, Hospitalization Rates, Chronic Comorbid Conditions, and Mortality. Cureus.
Crossref
Haifa Alsadhan, Abdulrahman I Alfawzan, Amirah Yaqoub, Alyah Almoneef & Mohammad Almohideb. (2022) Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, and Risk Factors in Riyadh, Saudi Arabia. Cureus.
Crossref
Mahendra Pratap Kashyap, Jasim Khan, Rajesh Sinha, Lin Jin, Venkatram Atigadda, Jessy S. Deshane, Ayesha R. Ahmed, Ali Kilic, Chander Raman, M. Shahid Mukhtar, Craig A. Elmets & Mohammad Athar. (2022) Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling. Seminars in Cell & Developmental Biology.
Crossref
Georgios Kontochristopoulos, Aikaterini Tsiogka, Efthymia Agiasofitou, Anastasia Kapsiocha, Stergios Soulaidopoulos, Aikaterini I. Liakou, Stamatios Gregoriou & Dimitrios Rigopoulos. (2022) Efficacy of Subantimicrobial, Modified-Release Doxycycline Compared to Regular-Release Doxycycline for the Treatment of Hidradenitis Suppurativa. Skin Appendage Disorders 8:6, pages 476-481.
Crossref
Xiaoxiao Hou, Amir M. Hossini, Georgios Nikolakis, Ottfried Balthasar, Andreas Kurtz & Christos C. Zouboulis. (2022) 3D-SeboSkin Model for Human ex vivo Studies of Hidradenitis Suppurativa/Acne Inversa. Dermatology 238:2, pages 236-243.
Crossref
Ximena Wortsman & Indermeet Kohli. 2022. A Comprehensive Guide to Hidradenitis Suppurativa. A Comprehensive Guide to Hidradenitis Suppurativa 45 61 .
Farah Succaria, Michelle L. Kerns & Angel S. Byrd. 2022. A Comprehensive Guide to Hidradenitis Suppurativa. A Comprehensive Guide to Hidradenitis Suppurativa 37 44 .
Dhanashree Bhide. 2022. Skin Diseases in Females. Skin Diseases in Females 153 179 .
Viktor A. Zouboulis, Konstantin C. Zouboulis & Christos C. Zouboulis. (2021) Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis. Pharmaceutics 14:1, pages 44.
Crossref
Vivian J. Hua, James M. Kilgour, Hyunje G. Cho, Shufeng Li & Kavita Y. Sarin. (2021) Characterization of comorbidity heterogeneity among 13,667 patients with hidradenitis suppurativa. JCI Insight 6:21.
Crossref
Tatsuya Dokoshi, Jason S. Seidman, Kellen J. Cavagnero, Fengwu Li, Marc C. Liggins, Bryn C. Taylor, Jocelyn Olvera, Rob Knight, John T. Chang, Nita H. Salzman & Richard L. Gallo. (2021) Skin inflammation activates intestinal stromal fibroblasts and promotes colitis. Journal of Clinical Investigation 131:21.
Crossref
Ana Preda‐Naumescu, Hana N. Ahmed, Tiffany T. Mayo & Nabiha Yusuf. (2021) Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations. International Journal of Dermatology 60:11.
Crossref
Sophie Glatt, Gregor B. E. Jemec, Seth Forman, Christopher Sayed, George Schmieder, Jamie Weisman, Robert Rolleri, Seth Seegobin, Dominique Baeten, Lucian Ionescu, Christos C. Zouboulis & Stevan Shaw. (2021) Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa. JAMA Dermatology 157:11, pages 1279.
Crossref
Christos C. Zouboulis & E. von Stebut. (2021) Hidradenitis suppurativa/Acne inversa: Von „orphan disease“ zu heilbarer entzündlicher HauterkrankungHidradenitis suppurativa/acne inversa: From “orphan disease” to a curable inflammatory skin disorder. Der Hautarzt 72:8, pages 647-650.
Crossref
Abdulhadi Jfri, David Nassim, Elizabeth O’Brien, Wayne Gulliver, Georgios Nikolakis & Christos C. Zouboulis. (2021) Prevalence of Hidradenitis Suppurativa. JAMA Dermatology 157:8, pages 924.
Crossref
Pelin Esme, Gulsen Akoglu, Oktay Sari & Ercan Caliskan. (2021) Family physicians’ awareness and general knowledge of hidradenitis suppurativa: A survey research. International Journal of Clinical Practice 75:7.
Crossref
Chung-Min Yoon, Jung-Ha Kwak, Song-Hee Han & Ji-An Choi. (2021) Follicular Occlusion Triad: A Case Report. Journal of Wound Management and Research 17:2, pages 125-130.
Crossref
Marilyn Boo, Lois Eva, Mayada Kellow & James Scurry. (2021) Vulval squamous cell carcinoma arising from hidradenitis suppurrativa. BMJ Case Reports 14:6, pages e241075.
Crossref
Evangelos J. Giamarellos‐Bourboulis, Vincenzo Bettoli, Gregor B. E. Jemec, Veronique del Marmol, Angelo V. Marzano, Errol P. Prens, Thrasyvoulos Tzellos & Christos C. Zouboulis. (2021) Anti‐COVID‐19 measurements for hidradenitis suppurativa patients. Experimental Dermatology 30:S1, pages 18-22.
Crossref
Alex Bató, Valentin Brodszky, L. Hunor Gergely, Krisztián Gáspár, Norbert Wikonkál, Ágnes Kinyó, Ákos Szabó, Zsuzsanna Beretzky, Andrea Szegedi, Éva Remenyik, Norbert Kiss, Miklós Sárdy & Fanni Rencz. (2021) The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa. Quality of Life Research 30:5, pages 1477-1490.
Crossref
Muskaan Sachdeva, Monica Shah & Afsaneh Alavi. (2020) Race-Specific Prevalence of Hidradenitis Suppurativa. Journal of Cutaneous Medicine and Surgery 25:2, pages 177-187.
Crossref
DincyC. V Peter, FrancesJ. D Smith, NeilJ Wilson & Sumita Danda. (2021) PSENEN mutation in coexistent hidradenitis suppurativa and dowling-degos disease. Indian Dermatology Online Journal 12:1, pages 147.
Crossref
Elia Rosi, Maria Thais Fastame, Leonardo Pescitelli, Antonella Di Cesare, Federica Ricceri, Nicola Pimpinelli & Francesca Prignano. (2021) Intellectual Disability and Hidradenitis Suppurativa. Dermatology 237:3, pages 386-388.
Crossref
Georgios Nikolakis, Katarzyna P. Kaleta, Aristeidis G. Vaiopoulos, Katja Wolter, Sumer Baroud, Anna Wojas-Pelc & Christos C. Zouboulis. (2021) Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review. Dermatology 237:5, pages 673-697.
Crossref
Aleksi J. Hendricks, Jennifer L. Hsiao, Michelle A. Lowes & Vivian Y. Shi. (2021) A Comparison of International Management Guidelines for Hidradenitis Suppurativa. Dermatology 237:1, pages 81-96.
Crossref
M.C. Schneeweiss, J.F. Merola, S. Schneeweiss, R. Wyss & D. Rosmarin. (2020) Risk of connective tissue disease, morphoea and systemic vasculitis in patients with hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology 35:1, pages 195-202.
Crossref
Sydney R Resnik, Emily L Geisler, Nicolas Reyes, Juan Lozano, Rafael Ramirez-Caussade & Barry I Resnik. (2020) Prevalence and Risk Factors for Anemia in a Population With Hidradenitis Suppurativa. Cureus.
Crossref
Ji-Eun Chang & Min Sik Choi. (2020) A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders. International Journal of Molecular Sciences 21:23, pages 8960.
Crossref
Laure Guenin-Macé, Jean-David Morel, Jean-Marc Doisne, Angèle Schiavo, Lysiane Boulet, Véronique Mayau, Pedro Goncalves, Sabine Duchatelet, Alain Hovnanian, Vincent Bondet, Darragh Duffy, Marie-Noëlle Ungeheuer, Maïa Delage, Aude Nassif, James P. Di Santo & Caroline Demangel. (2020) Dysregulation of tryptophan catabolism at the host-skin microbiota interface in hidradenitis suppurativa. JCI Insight 5:20.
Crossref
J. W. Frew, C. S. Jiang, N. Singh, D. Grand, K. Navrazhina, R. Vaughan & J. G. Krueger. (2020) Malignancy and infection risk during adalimumab therapy in hidradenitis suppurativa. Clinical and Experimental Dermatology 45:7, pages 859-865.
Crossref
Marcos A. González-López, Iosune Vilanova, Gonzalo Ocejo-Viñals, Rubén Arlegui, Iñigo Navarro, Sandra Guiral, Cristina Mata, M. Genma Pérez-Paredes, Virginia Portilla, Alfonso Corrales, M. Carmen González-Vela, Miguel A. González-Gay, Ricardo Blanco & José L. Hernández. (2019) Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa. Archives of Dermatological Research 312:8, pages 595-600.
Crossref
Khalaf Kridin, Virginia A. Jones, Payal M. Patel, Frederick T. Gibson, Kyle T. Amber & Arnon D. Cohen. (2020) Hidradenitis suppurativa and pemphigus: a cross-sectional study. Archives of Dermatological Research 312:7, pages 501-505.
Crossref
Andreas Pinter, Georgios Kokolakis, Juergen Rech, Mona H. C. Biermann, Benjamin M. Häberle, Jan Multmeier & Maximilian Reinhardt. (2020) Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors. Dermatology and Therapy 10:4, pages 721-734.
Crossref
Vishnu Hosur, Daniel A. Skelly, Christopher Francis, Benjamin E. Low, Vivek Kohar, Lisa M. Burzenski, Mansoor M. Amiji, Leonard D. Shultz & Michael V. Wiles. (2020) Improved mouse models and advanced genetic and genomic technologies for the study of neutrophils. Drug Discovery Today 25:6, pages 1013-1025.
Crossref
Shashank Bhargava, Nils Becker & George Kroumpouzos. (2020) Atypical Clinical Presentation of Hidradenitis Suppurativa in a Patient with Severe Mannose-Binding Lectin Deficiency. Case Reports in Dermatology 12:2, pages 83-91.
Crossref
C.C. Zouboulis, A. Nogueira da Costa, E. Makrantonaki, X.X. Hou, D. Almansouri, J.T. Dudley, H. Edwards, B. Readhead, O. Balthasar, G.B.E. Jemec, N.G. Bonitsis, G. Nikolakis, D. Trebing, K.C. Zouboulis & A.M. Hossini. (2020) Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology 34:4, pages 846-861.
Crossref
Ciro EspositoFulvia Del ConteMariapina CeruloVincenzo CoppolaGiovanni EspositoElisabetta RicciardiMarco CastagnettiGabriella FabbrociniMaria Escolino. (2020) Pediatric Endoscopic Hidradenitis Treatment: A New Minimally Invasive Treatment for Pediatric Patients with Hidradenitis Suppurativa. Journal of Laparoendoscopic & Advanced Surgical Techniques 30:4, pages 464-470.
Crossref
I. Iesalnieks & U. Dornseifer. (2020) Acne inversa (Hidradenitis suppurativa)Acne inversa (hidradenitis suppurativa). Der Chirurg 91:4, pages 293-300.
Crossref
Kevin Phan, Artiene Tatian, Jane Woods, Geoffrey Cains & John W. Frew. (2019) Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta‐analysis. International Journal of Dermatology 59:2, pages 221-228.
Crossref
Kevin Phan, Olivia Charlton & Saxon D Smith. (2019) Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta‐analysis. Australasian Journal of Dermatology 61:1.
Crossref
Thrasyvoulos Tzellos & Christos C. Zouboulis. (2020) Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice. Dermatology and Therapy 10:1, pages 63-71.
Crossref
Kevin Phan, Ya Ruth Huo, Olivia Charlton & Saxon D. Smith. (2019) Hidradenitis Suppurativa and Thyroid Disease: Systematic Review and Meta-Analysis. Journal of Cutaneous Medicine and Surgery 24:1, pages 23-27.
Crossref
Dana Tzur Bitan, Daniella Berzin & Arnon Cohen. (2020) Hidradenitis Suppurativa and Bipolar Disorders: A Population-Based Study. Dermatology 236:4, pages 298-304.
Crossref
H. Hande Aydinli & Emre Gorgun. 2020. Clinical Decision Making in Colorectal Surgery. Clinical Decision Making in Colorectal Surgery 169 177 .
Raffaele Dante Caposiena Caro. 2020. Image Guided Dermatologic Treatments. Image Guided Dermatologic Treatments 15 31 .
C. Durán‐Vian, M.T. Arias‐Loste, J.L. Hernández, V. Fernández, M. González, P. Iruzubieta, L. Rasines, C. González‐Vela, J.P. Vaqué, R. Blanco, J. Crespo & M.A. González‐López. (2019) High prevalence of non‐alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors. Journal of the European Academy of Dermatology and Venereology 33:11, pages 2131-2136.
Crossref
Theresa Stockinger, Nikolaus Lilgenau & Klemens Rappersberger. (2019) Therapiestandards der Acne inversa. hautnah dermatologie 35:6, pages 46-51.
Crossref
Caitlyn Duran & Angela Baumeister. (2019) Recognition, diagnosis, and treatment of hidradenitis suppurativa. JAAPA 32:10, pages 36-42.
Crossref
S.E. Marrón, M. Gómez-Barrera, L. Tomás-Aragonés, R.M. Díaz Díaz, E. Vilarrasa Rull, M.B. Madrid Álvarez & L. Puig. (2019) Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis Suppurativa. Actas Dermo-Sifiliográficas (English Edition) 110:7, pages 554-560.
Crossref
S.E. Marrón, M. Gómez-Barrera, L. Tomás-Aragonés, R.M. Díaz Díaz, E. Vilarrasa Rull, M.B. Madrid Álvarez & L. Puig. (2019) Desarrollo y validación preliminar del instrumento HSQoL-24 para evaluar calidad de vida en pacientes con hidradenitis supurativa. Actas Dermo-Sifiliográficas 110:7, pages 554-560.
Crossref
Wei-Ti Chen & Ching-Chi Chi. (2019) Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease. JAMA Dermatology 155:9, pages 1022.
Crossref
Ali Alikhan, Christopher Sayed, Afsaneh Alavi, Raed Alhusayen, Alain Brassard, Craig Burkhart, Karen Crowell, Daniel B. Eisen, Alice B. Gottlieb, Iltefat Hamzavi, Paul G. Hazen, Tara Jaleel, Alexa B. Kimball, Joslyn Kirby, Michelle A. Lowes, Robert Micheletti, Angela Miller, Haley B. Naik, Dennis Orgill & Yves Poulin. (2019) North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Journal of the American Academy of Dermatology 81:1, pages 76-90.
Crossref
Ø. Grimstad, T. Tzellos, D.N. Dufour, Ø. Bremnes, I.M. Skoie, I. Snekvik, E. Jarnæss, A. Kyrgidis & G. Ingvarsson. (2019) Evaluation of medical and surgical treatments for hidradenitis suppurativa using real‐life data from the Scandinavian registry ( HISREG ) . Journal of the European Academy of Dermatology and Venereology 33:6, pages 1164-1171.
Crossref
A. Rondags, K.R. Straalen, J.R. Hasselt, I.C. Janse, C.B. Ardon, A.R.J.V. Vossen, E.P. Prens, H.H. Zee & B. Horváth. (2019) Correlation of the refined Hurley classification for hidradenitis suppurativa with patient‐reported quality of life and objective disease severity assessment. British Journal of Dermatology 180:5, pages 1214-1220.
Crossref
Marion Fauconier, Ziad Reguiai, Coralie Barbe, Alban Colosio, Jean-Paul Eschard, Jean-Hugues Salmon & Guillaume Direz. (2019) Association entre hidrosadénite suppurative et spondyloarthrite. Revue du Rhumatisme 86:3, pages 283-287.
Crossref
Giovanni Damiani, Sebastiano Leone, Kristen Fajgenbaum, Nicola L Bragazzi, Alessia Pacifico, Rosalynn RZ Conic, Paolo DM Pigatto, Carlo Maiorana, Pierpaolo Poli, Emilio Berti, Maria C Pace, Piergiorgio Malagoli, Vincenzo Bettoli & Marco Fiore. (2019) Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World Journal of Hepatology 11:4, pages 391-401.
Crossref
Renata Ferreira Magalhães, Maria Cecília Rivitti-Machado, Gleison Vieira Duarte, Roberto Souto, Daniel Holthausen Nunes, Mario Chaves, Sérgio Henrique Hirata & Andrea Machado Coelho Ramos. (2019) Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology. Anais Brasileiros de Dermatologia 94:2 suppl 1, pages 7-19.
Crossref
Sofia Lopes, Júlia Vide, Miguel Costa-Silva, Filomena Azevedo & Sofia Magina. (2019) Awareness, knowledge, and practice patterns of general practitioner residents and specialists toward hidradenitis suppurativa: a survey study. Acta Dermatovenerologica Alpina Pannonica et Adriatica 28:2.
Crossref
Costas A Constantinou, George E Fragoulis & Elena Nikiphorou. (2019) Hidradenitis suppurativa: infection, autoimmunity, or both?. Therapeutic Advances in Musculoskeletal Disease 11, pages 1759720X1989548.
Crossref
Christos C. Zouboulis, André Nogueira da Costa, Gregor B.E. Jemec & Dietrich Trebing. (2019) Long-Wave Medical Infrared Thermography: A Clinical Biomarker of Inflammation in Hidradenitis Suppurativa/Acne Inversa. Dermatology 235:2, pages 144-149.
Crossref
Christos C. Zouboulis & André Nogueira da Costa. (2019) Standardized Photographic Documentation of Hidradenitis Suppurativa/Acne Inversa. Dermatology 235:1, pages 51-54.
Crossref
C.C. Zouboulis, F.G. Bechara, J.L. Dickinson‐Blok, W. Gulliver, B. Horváth, R. Hughes, A.B. Kimball, B. Kirby, A. Martorell, M. Podda, E.P. Prens, H.C. Ring, T. Tzellos, H.H. van der Zee, K.R. van Straalen, A.R.J.V. Vossen & G.B.E. Jemec. (2018) Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group. Journal of the European Academy of Dermatology and Venereology 33:1, pages 19-31.
Crossref
Rasa Aurelija Vankevicčiūtė, Brigita Polozovaitė, Julius Trapikas, Tadas Raudonis, Jūratė Grigaitienė & Matilda Bylaitė-Bucčinskienė. (2019) A 12-Year Experience of Hidradenitis Suppurativa Management. Advances in Skin & Wound Care 32:1, pages 1-7.
Crossref
Devrim Isbir & C. Can Cedidi. 2019. Intimchirurgie. Intimchirurgie 243 251 .
Alexandra B. Kimball, Murali Sundaram, Genevieve Gauthier, Annie Guérin, Irina Pivneva, Rakesh Singh & Arijit Ganguli. (2018) The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis. Dermatology and Therapy 8:4, pages 557-569.
Crossref
J.H. Lee, H.S. Kwon, H.M. Jung, G.M. Kim & J.M. Bae. (2018) Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population‐based study. Journal of the European Academy of Dermatology and Venereology 32:10, pages 1784-1790.
Crossref
Marion Fauconier, Ziad Reguiai, Coralie Barbe, Alban Colosio, Jean-Paul Eschard, Jean-Hugues Salmon & Guillaume Direz. (2018) Association between hidradenitis suppurativa and spondyloarthritis. Joint Bone Spine 85:5, pages 593-597.
Crossref
Anna Campanati, Monia Orciani, Giulia Sorgentoni, Veronica Consales, Annamaria Offidani & Roberto Di Primio. (2018) Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa. JAMA Dermatology 154:10, pages 1184.
Crossref
Amira A. Abdel Azim, Rania T. Salem & Rania Abdelghani. (2018) Combined fractional carbon dioxide laser and long-pulsed neodymium : yttrium-aluminium-garnet (1064 nm) laser in treatment of hidradenitis suppurativa; a prospective randomized intra-individual controlled study. International Journal of Dermatology 57:9, pages 1135-1144.
Crossref
Amit Garg, Jessica Hundal & Andrew Strunk. (2018) Overall and Subgroup Prevalence of Crohn Disease Among Patients With Hidradenitis Suppurativa. JAMA Dermatology 154:7, pages 814.
Crossref
B.C. Melnik, S.M. John, W. Chen & G. Plewig. (2018) T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities. British Journal of Dermatology.
Crossref
Marta C. García Bustínduy. (2018) Afectación psicosocial en el paciente con hidradenitis supurativa. Piel 33:6, pages 371-376.
Crossref
I. Vilanova, J.L. Hernández, C. Mata, C. Durán, M.T. García-Unzueta, V. Portilla, P. Fuentevilla, A. Corrales, M.C. González-Vela, M.A. González-Gay, R. Blanco & M.A. González-López. (2018) Insulin resistance in hidradenitis suppurativa: a case-control study. Journal of the European Academy of Dermatology and Venereology 32:5, pages 820-824.
Crossref
Geraldine O’Sullivan Coyne, Therese S. Woodring, Chyi-Chia R. Lee, Alice P. Chen & Heidi H. Kong. (2018) Hidradenitis Suppurativa-Like Lesions Associated with Pharmacologic Inhibition of Gamma-Secretase. Journal of Investigative Dermatology 138:4, pages 979-981.
Crossref
Ali Balevi, Pelin Ustuner & Mustafa Özdemir. (2018) The efficacy of adalimumab in the treatment of hidradenitis suppurativa. Dicle Tıp Dergisi 45:1, pages 19-27.
Crossref
Thanh-Lan Bui, Catalina Silva-Hirschberg, Josefina Torres & April W. Armstrong. (2018) Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 78:2, pages 395-402.
Crossref
Marcos A. González-López, Marina Lacalle, Cristina Mata, María López-Escobar, Alfonso Corrales, Raquel López-Mejías, Javier Rueda, M. Carmen González-Vela, Miguel A. González-Gay, Ricardo Blanco & José L. Hernández. (2018) Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa. PLOS ONE 13:1, pages e0190568.
Crossref
E. Dauden, P. Lazaro, M.D. Aguilar, A.J. Blasco, C. Suarez, I. Marin, R. Queiro, J. Bassas‐Vila, A. Martorell & J. García‐Campayo. (2017) Recommendations for the management of comorbidity in hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology 32:1, pages 129-144.
Crossref
Angelo Valerio Marzano, Giovanni Damiani & Alessandro Borghi. 2018. Neutrophilic Dermatoses. Neutrophilic Dermatoses 151 168 .
Christos C. Zouboulis & Mankul Goyal. 2018. Pigmented Ethnic Skin and Imported Dermatoses. Pigmented Ethnic Skin and Imported Dermatoses 219 228 .
Rajshree Jayarajan & Agata Bulinska. (2017) Editor’s Pick: Hidradenitis Suppurativa (Acne Inversa): A Review of Aetiopathogenesis and Management. EMJ Dermatology, pages 66-73.
Crossref
Afsaneh Alavi, Charles Lynde, Raed Alhusayen, Marc Bourcier, Isabelle Delorme, Ralph George, Melinda Gooderham, Wayne Gulliver, Sunil Kalia, Danielle Marcoux & Yves Poulin. (2017) Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document. Journal of Cutaneous Medicine and Surgery 21:6, pages 513-524.
Crossref
C.C. Zouboulis, T. Tzellos, A. Kyrgidis, G.B.E. Jemec, F.G. Bechara, E.J. Giamarellos‐Bourboulis, J.R. Ingram, T. Kanni, I. Karagiannidis, A. Martorell, Ł. Matusiak, A. Pinter, E.P. Prens, D. Presser, S. Schneider‐Burrus, E. von Stebut, J.C. Szepietowski, H.H. Zee, S.M. Wilden, R. Sabat, R. Sinclair, D. Vekic, P. Haes, V. Marmol, A. Alavi, W. Gulliver, A. Nassif, G. Nikolakis, M. Podda, C. Antoniou, F.S. Delli, C. Dessinioti, A. Patsatsi, A.P. Trigoni, C. Zisimou, V. Bettoli, S. Garcovich, J. Boer, B. Horváth, G. Ingvarsson, L. Puig, R.E. Hunger, L. Emtestam, F.W. Danby & A.B. Kimball. (2017) Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severity . British Journal of Dermatology 177:5, pages 1401-1409.
Crossref
Ahmed Shah, Raed Alhusayen & Saeid Amini-Nik. (2017) The critical role of macrophages in the pathogenesis of hidradenitis suppurativa. Inflammation Research 66:11, pages 931-945.
Crossref
Emma Fanning & Donal O'Shea. (2017) Genetics and the Metabolic Syndrome. Clinics in Dermatology.
Crossref
M. A. González-López, J. L. Hernández, I. Vilanova, C. Mata, M. López-Escobar, M. C. González-Vela, M. López-Hoyos, M. A. González-Gay & R. Blanco. (2017) Thyroid autoimmunity in patients with hidradenitis suppurativa: a case-control study. Clinical and Experimental Dermatology 42:6, pages 642-644.
Crossref
Mohammed Dany & Dirk Elston. (2017) Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa. Journal of the American Academy of Dermatology 77:2, pages 268-273.e6.
Crossref
A. Cices, E. Ibler, S. Majewski, T. Huynh, K.A. Sable, J. Brieva, D.P. West & B. Nardone. (2017) Hidradenitis suppurativa association at the time of, or subsequent to, diagnosis of inflammatory bowel disease in a large U.S. patient population. Journal of the European Academy of Dermatology and Venereology 31:7, pages e311-e312.
Crossref
Rowan Hillson. (2017) Sweating in diabetes. Practical Diabetes 34:4, pages 114-115.
Crossref
N. DesaiP. Shah. (2017) High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics. British Journal of Dermatology 176:4, pages 1048-1055.
Crossref
Gabriella Fabbrocini, Eleonora Ruocco, Valerio De Vita & Giuseppe Monfrecola. (2017) Squamous cell carcinoma arising in long-standing hidradenitis suppurativa: An overlooked facet of the immunocompromised district. Clinics in Dermatology 35:2, pages 225-227.
Crossref
Mallory K Smith, Cynthia L Nicholson, Angela Parks-Miller & Iltefat H Hamzavi. (2017) Hidradenitis suppurativa: an update on connecting the tracts. F1000Research 6, pages 1272.
Crossref
Alexandros C. Katoulis, Aikaterini I. Liakou, Nikolaos Rotsiamis, Stefanos Bonovas, Evangelia Bozi, Efstathios Rallis, Christos Christodoulou & Dimitrios Rigopoulos. (2017) Descriptive Epidemiology of Hidradenitis Suppurativa in Greece: A Study of 152 Cases. Skin Appendage Disorders 3:4, pages 197-201.
Crossref
Uwe Wollina, Dana Langner, Birgit Heinig & Andreas Nowak. (2017) Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center report. International Journal of Dermatology 56:1, pages 109-115.
Crossref
George Denny & Milan J. Anadkat. (2017) The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study. Journal of the American Academy of Dermatology 76:1, pages 54-59.
Crossref
Dubravka Bosnić, Branimir Žarković, Marko Barešić, Maja Zarkovic & Branimir Anić. (2016) Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab. Rheumatology 54:6, pages 321-325.
Crossref
Nemesha Desai, Hessel H. van der Zee & Gregor B. E. Jemec. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition 1 12 .
Ioannis Karagiannidis, Georgios Nikolakis, Robert Sabat & Christos C. Zouboulis. (2016) Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?. Reviews in Endocrine and Metabolic Disorders 17:3, pages 335-341.
Crossref
Wayne Gulliver, Christos C. Zouboulis, Errol Prens, Gregor B. E. Jemec & Thrasivoulos Tzellos. (2016) Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Reviews in Endocrine and Metabolic Disorders 17:3, pages 343-351.
Crossref
Alexa B. Kimball, Martin M. Okun, David A. Williams, Alice B. Gottlieb, Kim A. Papp, Christos C. Zouboulis, April W. Armstrong, Francisco Kerdel, Michael H. Gold, Seth B. Forman, Neil J. Korman, Evangelos J. Giamarellos-Bourboulis, Jeffrey J. Crowley, Charles Lynde, Ziad Reguiai, Errol-Prospero Prens, Eihab Alwawi, Nael M. Mostafa, Brett Pinsky, Murali Sundaram, Yihua Gu, Dawn M. Carlson & Gregor B.E. Jemec. (2016) Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. New England Journal of Medicine 375:5, pages 422-434.
Crossref
M. Daxhelet, M. Suppa, F. Benhadou, V. Djamei, T. Tzellos, G. Ingvarsson, J. Boer, A. Martorell, J.R. Ingram, N. Desai, A. Nassif, J. Revuz, C. Hotz, V. Bettoli, I.E. Deckers, G.B. Jemec, E. Prens, C.C. Zouboulis & V. del Marmol. (2016) Establishment of a European Registry for hidradenitis suppurativa/acne inversa by using an open source software. Journal of the European Academy of Dermatology and Venereology 30:8, pages 1424-1426.
Crossref
Marcos A. Gonz?lez-L?pez, Jos? L. Hern?ndez, Marina Lacalle, Cristina Mata, Mar?a L?pez-Escobar, Raquel L?pez-Mej?as, Virginia Portilla, Patricia Fuentevilla, Alfonso Corrales, M. Carmen Gonz?lez-Vela, Miguel A. Gonz?lez-Gay & Ricardo Blanco. (2016) Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS). Journal of the American Academy of Dermatology 75:2, pages 329-335.
Crossref
O. Yu Olisova, E. S Snarskaya, O. V Grabovskaya, N. P Tepluyk, Anfisa A. Lepekhova & A. S Gasymova. (2016) A rare combination of inverse acne and infiltrative-productive stage of rosacea. Russian Journal of Skin and Venereal Diseases 19:3, pages 158-161.
Crossref
S. A Masyukova, V. V Mordovtseva, Inna V. Ilina, E. G Sanakoeva, Z. A Alieva, D. V Grebenyuk & E. I Gubanova. (2016) Hidradenitis suppurativa: clinic and diagnostics (part 2). Russian Journal of Skin and Venereal Diseases 19:3, pages 154-158.
Crossref
A.B. Kimball, J.M. Sobell, C.C. Zouboulis, Y. Gu, D.A. Williams, M. Sundaram, H.D. Teixeira & G.B.E. Jemec. (2015) HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo‐controlled portion of a phase 2 adalimumab study. Journal of the European Academy of Dermatology and Venereology 30:6, pages 989-994.
Crossref
Coline Faivre, Axel Patrice Villani, François Aubin, Dan Lipsker, Martine Bottaro, Jean-David Cohen, François Durupt, Géraldine Jeudy, Emilie Sbidian, Eric Toussirot, Valérie Badot, Sébastien Barbarot, Sébastien Debarbieux, Emmanuel Delaporte, Guetty Goegebeur, Jacques Morel, Aude Nassif, Gérard Duru & Denis Jullien. (2016) Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases. Journal of the American Academy of Dermatology 74:6, pages 1153-1159.
Crossref
Ganesh Gajanan, Chandrashekar Bohra, Sowmya Nanjappa & John N. Greene. (2016) Chronic Infections Leading to Squamous Cell Carcinoma From Chronic Inflammation. Infectious Diseases in Clinical Practice 24:3, pages 133-137.
Crossref
S. A Masyukova, V. V Mordovtseva, Inna V. Ilina, E. G Sanakoeva, Z. A Alieva, D. V Grebenyuk & Yu. P Sokolova. (2016) Hydradenitis suppurativa: etiology, pathogenesis and treatment. Russian Journal of Skin and Venereal Diseases 19:1, pages 23-26.
Crossref
Dan Lipsker, François Severac, Marie Freysz, Eric Sauleau, Jurr Boer, Lennart Emtestam, Łukasz Matusiak, Errol Prens, Charles Velter, Cédric Lenormand, Nicolas Meyer & Gregor B.E. Jemec. (2016) The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions. Dermatology 232:2, pages 137-142.
Crossref
Mathieu Leuenberger, Jeanne Berner, Julie Di Lucca, Lara Fischer, Nikolaos Kaparos, Curdin Conrad, Daniel Hohl, Alexander So & Michel Gilliet. (2016) PASS Syndrome: An IL-1-Driven Autoinflammatory Disease. Dermatology 232:2, pages 254-258.
Crossref
Marcos A. González-López, Ricardo Blanco, Cristina Mata, María López-Escobar, Marina Lacalle, Germana Consuegra, M. Carmen González-Vela & Miguel A. González-Gay. (2016) Coexistence of Hidradenitis Suppurativa with Autoimmune Thyroiditis: Report of Three Cases. Dermatology 232:2, pages 162-164.
Crossref
Alice Verdelli, Emiliano Antiga, Diletta Bonciani, Veronica Bonciolini, Walter Volpi & Marzia Caproni. (2016) A fatal case of hidradenitis suppurativa associated with sepsis and squamous cell carcinoma. International Journal of Dermatology 55:1, pages e52-e53.
Crossref
Dominique C. van Rappard, Jan R. Mekkes & Thrasivoulos Tzellos. (2016) Randomized Controlled Trials for the Treatment of Hidradenitis Suppurativa. Dermatologic Clinics 34:1, pages 69-80.
Crossref
Jurr Boer, Maiwand Nazary & Peter Theut Riis. (2016) The Role of Mechanical Stress in Hidradenitis Suppurativa. Dermatologic Clinics 34:1, pages 37-43.
Crossref
S. Mühl & O. Schwandner. 2016. Proktologische Diagnostik. Proktologische Diagnostik 225 232 .
Eric K. Johnson. 2016. The ASCRS Textbook of Colon and Rectal Surgery. The ASCRS Textbook of Colon and Rectal Surgery 289 307 .
R.C. Simpson. (2015) Cardiovascular disease risk factors in patients with hidradenitis suppurativa. British Journal of Dermatology 173:5, pages 1118-1119.
Crossref
T. Tzellos, C.C. Zouboulis, W. Gulliver, A.D. Cohen, P. Wolkenstein & G.B.E. Jemec. (2015) Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. British Journal of Dermatology 173:5, pages 1142-1155.
Crossref
V. Bettoli, M. Ricci, S. Zauli & A. Virgili. (2015) Hidradenitis suppurativa-acne inversa: a relevant dermatosis in paediatric patients. British Journal of Dermatology 173:5, pages 1328-1330.
Crossref
John J. Kohorst, Alexa B. Kimball & Mark D.P. Davis. (2015) Systemic associations of hidradenitis suppurativa. Journal of the American Academy of Dermatology 73:5, pages S27-S35.
Crossref
A. Martorell, F.J. García, D. Jiménez-Gallo, J.C. Pascual, J. Pereyra-Rodríguez, L. Salgado & E. Vilarrasa. (2015) Update on Hidradenitis Suppurative (Part II): Treatment. Actas Dermo-Sifiliográficas (English Edition) 106:9, pages 716-724.
Crossref
A. Martorell, F.J. García-Martínez, D. Jiménez-Gallo, J.C. Pascual, J. Pereyra-Rodriguez, L. Salgado & E. Vilarrasa. (2015) An Update on Hidradenitis Suppurativa (Part I): Epidemiology, Clinical Aspects, and Definition of Disease Severity. Actas Dermo-Sifiliográficas (English Edition) 106:9, pages 703-715.
Crossref
A. Martorell, F.J. Garc?a, D. Jim?nez-Gallo, J.C. Pascual, J. Pereyra-Rodr?guez, L. Salgado & E. Villarrasa. (2015) Actualizaci?n en hidradenitis supurativa (ii): aspectos terap?uticos. Actas Dermo-Sifiliogr?ficas 106:9, pages 716-724.
Crossref
A. Martorell, F.J. García-Martínez, D. Jiménez-Gallo, J.C. Pascual, J. Pereyra-Rodriguez, L. Salgado & E. Vilarrasa. (2015) Actualización en hidradenitis supurativa (I): epidemiología, aspectos clínicos y definición de severidad de la enfermedad. Actas Dermo-Sifiliográficas 106:9, pages 703-715.
Crossref
Antonia Brandt, Annett Milling & Christos C. Zouboulis. (2015) Langwierige Diagnose, hohe Rezidivrate. hautnah dermatologie 31:6, pages 40-47.
Crossref
J.M. Carrascosa, J. Bassas & L. Puig. (2015) Hidradenitis Suppurativa: New Opportunities for an Orphan Skin Disease. Actas Dermo-Sifiliográficas (English Edition) 106:6, pages 448-451.
Crossref
J.M. Carrascosa, J. Bassas & L. Puig. (2015) Hidradenitis supurativa: nuevas oportunidades para una enfermedad dermatol?gica hu?rfana. Actas Dermo-Sifiliogr?ficas 106:6, pages 448-451.
Crossref
C.C. Zouboulis, N. Desai, L. Emtestam, R.E. Hunger, D. Ioannides, I. Juhász, J. Lapins, L. Matusiak, E.P. Prens, J. Revuz, S. Schneider-Burrus, J.C. Szepietowski, H.H. van der Zee & G.B.E. Jemec. (2015) European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Journal of the European Academy of Dermatology and Venereology 29:4, pages 619-644.
Crossref
J. Revuz. (2015) Hidradenitis supurativa. EMC - Dermatología 49:1, pages 1-16.
Crossref
Christos C. Zouboulis, Veronique del Marmol, Ulrich Mrowietz, Errol P. Prens, Thrasivoulos Tzellos & Gregor B.E. Jemec. (2015) Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation. Dermatology 231:2, pages 184-190.
Crossref
J.J. Crowley, J.R. Mekkes, C.C. Zouboulis, N. Scheinfeld, A. Kimball, M. Sundaram, Y. Gu, M.M. Okun & F. Kerdel. (2014) Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. British Journal of Dermatology 171:6, pages 1561-1565.
Crossref
Clio Dessinioti, Andreas Katsambas & Christina Antoniou. (2014) Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clinics in Dermatology 32:3, pages 397-408.
Crossref
Deirdre Nathalie Dufour, Lennart Emtestam & Gregor B Jemec. (2014) Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgraduate Medical Journal 90:1062, pages 216-221.
Crossref
Inge E. Deckers, Hessel H. van der Zee & Errol P. Prens. (2013) Epidemiology of Hidradenitis Suppurativa: Prevalence, Pathogenesis, and Factors Associated with the Development of HS. Current Dermatology Reports 3:1, pages 54-60.
Crossref
D. Badr, M. Kurban & O. Abbas. (2013) Metformin in dermatology: an overview. Journal of the European Academy of Dermatology and Venereology 27:11, pages 1329-1335.
Crossref
Andrzej Slominski, Blazej Zbytek, Georgios Nikolakis, Pulak R. Manna, Cezary Skobowiat, Michal Zmijewski, Wei Li, Zorica Janjetovic, Arnold Postlethwaite, Christos C. Zouboulis & Robert C. Tuckey. (2013) Steroidogenesis in the skin: Implications for local immune functions. The Journal of Steroid Biochemistry and Molecular Biology 137, pages 107-123.
Crossref
C.W. Wieland, T. Vogl, A. Ordelman, H.G.M. Vloedgraven, L.H.A. Verwoolde, J.M. Rensen, J. Roth, J. Boer & J. Hessels. (2013) Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?. British Journal of Dermatology 168:6, pages 1252-1258.
Crossref
H.H. van der Zee & E.P. Prens. (2013) Failure of Anti-Interleukin-1 Therapy in Severe Hidradenitis Suppurativa: A Case Report. Dermatology 226:2, pages 97-100.
Crossref
Ignacio Hernández Montilla, Alfonso Medela, Taig Mac Carthy, Andy Aguilar, Pedro Gómez Tejerina, Alejandro Vilas Sueiro, Ana María González Pérez, Laura Vergara de la Campa, Loreto Luna Bastante, Rubén García Castro & Fernando Alfageme Roldán. (2022) Automatic International Hidradenitis Suppurativa Severity Score System (AIHS4): A Novel Tool to Assess the Severity of Hidradenitis Suppurativa Using Artificial Intelligence. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.